Literature DB >> 671687

Screening and immunization of rubella-susceptible women. Experience in a large, prepaid medical group.

D M Shlian.   

Abstract

Four hundred and fifty childbearing-aged women were screened for rubella hemagglutination inhibition (HI) antibody after a clinical history of susceptibility was obtained. One hundred and forty-nine (33%) were found to be susceptible (titers less than 1:8), pointing out the need for a move active immunization program for susceptible young women and for routine vaccination of children. Clinical history correlated poorly with the level of HI antibody. One hundred percent of the patients were vaccinated and protective antibody titres developed in 97%. Since titers are higher after infection than after vaccination, periodic reevaluation of the vaccinated group may be indicated if immunity is to be ensured.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 671687

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  6 in total

1.  Risk of pregnancy among adolescent schoolgirls participating in a measles mass immunization program.

Authors:  J M Mann; J M Montes; H F Hull; N Greenberg; N Kalishman; A E Pressman; S G Kennedy; C T Iddings
Journal:  Am J Public Health       Date:  1983-05       Impact factor: 9.308

Review 2.  Rubella vaccination.

Authors:  J Forster
Journal:  Eur J Pediatr       Date:  1988-08       Impact factor: 3.183

3.  Rubella screening: organization and incentive.

Authors:  S Rowlands; R G Bethel
Journal:  J R Coll Gen Pract       Date:  1982-08

4.  Rubella susceptibility in inner-city adolescents: the effect of a school immunization law.

Authors:  D B Nelson; M M Layde; T B Chatton
Journal:  Am J Public Health       Date:  1982-07       Impact factor: 9.308

5.  Public health implications of rubella antibody levels in California.

Authors:  L G Dales; J Chin
Journal:  Am J Public Health       Date:  1982-02       Impact factor: 9.308

6.  An outbreak of congenital rubella.

Authors:  L G Dales; J Chin
Journal:  West J Med       Date:  1981-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.